China Universal Asset Management Company’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $670K | Buy |
21,245
+1,893
| +10% | +$59.7K | 0.06% | 219 |
|
|
2025
Q1 | $634K | Sell |
19,352
-514
| -3% | -$16.8K | 0.06% | 224 |
|
|
2024
Q4 | $718K | Buy |
19,866
+9,267
| +87% | +$335K | 0.07% | 207 |
|
|
2024
Q3 | $330K | Buy |
10,599
+4,140
| +64% | +$129K | 0.04% | 259 |
|
|
2024
Q2 | $173K | Sell |
6,459
-4,031
| -38% | -$108K | 0.02% | 258 |
|
|
2024
Q1 | $358K | Buy |
10,490
+4,176
| +66% | +$142K | 0.05% | 217 |
|
|
2023
Q4 | $183K | Buy |
6,314
+4,913
| +351% | +$142K | 0.04% | 213 |
|
|
2023
Q3 | $38.6K | Buy |
1,401
+687
| +96% | +$18.9K | 0.01% | 245 |
|
|
2023
Q2 | $21.5K | Sell |
714
-19
| -3% | -$571 | 0.01% | 262 |
|
|
2023
Q1 | $26.6K | Buy |
733
+184
| +34% | +$6.67K | 0.01% | 193 |
|
|
2022
Q4 | $19.6K | Buy |
549
+48
| +10% | +$1.71K | 0.01% | 173 |
|
|
2022
Q3 | $17K | Buy |
+501
| New | +$17K | 0.01% | 166 |
|